CELUW vs WST · rev $54.2M vs P/E 35, rev $1.72B
Celularity Inc (CELUW) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Celularity Inc (CELUW) common stock listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CELUW currently screens at market cap $0. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CELUW and WST stock pages for the full models.
Not investment advice.